The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.40
Bid: 144.60
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.277%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 144.40
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Elementis Trading Update

28 Oct 2016 07:00

ELEMENTIS PLC - Elementis Trading Update

ELEMENTIS PLC - Elementis Trading Update

PR Newswire

London, October 27

28 October 2016

Elementis – Trading Update

Elementis plc (ELM.L, “Elementis” or the “Group”), the Global Specialty Chemicals Company, today issues a trading update for the three months ended 30 September 2016.

Commenting on the Group’s performance Chief Executive Officer, Paul Waterman, said:

“We continue to focus on prioritising our strategic agenda, which we will present in more detail at the Group’s Capital Markets Day presentation on 14 November 2016. I am pleased to report continued progress in Specialty Products and while trading conditions for Chromium continued to be challenging, overall Group earnings per share for 2016 are expected to be in line with market expectations.

Specialty Products’ performance in the period was positive, with strong growth in Personal Care and improved performance in Latin America coatings.

In Chromium, although the environment internationally remains challenging, contribution margins in North America and the rest of the world were stable. We continue to look at options to increase efficiency to help offset the competitive effects of a stronger dollar.

Cash generation continues to be an important component of the Group’s performance and, as previously stated, the net cash balance at the end of the year is likely to be higher than at the same time last year which, under our progressive dividend policy, will have a positive effect on the special dividend.”

Specialty Products’ sales were 6 per cent higher than in the same period last year on a constant currency basis, and 4 per cent on a reported basis. The remainder of this business commentary refers to constant currency sales.

In Coatings, Asia Pacific sales were 5 per cent ahead of the prior year as demand in China continued to reflect solid underlying growth. Sales in Latin America showed significant growth in the period, despite ongoing economic challenges in Brazil. The business benefited from new business wins at key accounts in Brazil, Mexico and Chile, which resulted in sales being 38 per cent higher than in the same period last year. Sales in North America were at a similar level to the comparator period, as overall demand continued to be negatively influenced by the impact of the strong dollar on North American exporters. In Europe, following a relatively strong second quarter (+4 per cent), sales in the period were 5 per cent lower than in the same period last year. We saw reduced consumption across Europe through our distributor channel whilst sales to Eastern Europe were also lower.

In Personal Care, where the Group has recently added more resources, sales were 38 per cent higher than in the same period last year. Excellent progress was made in growing sales of hectorite products in colour cosmetics and antiperspirants, while expanding sales geographically also showed good progress, particularly in Italy, China, India and Brazil.

In Oilfield Drilling, sales were 4 per cent lower than in the same period last year as demand patterns continued to remain relatively stable.

In Chromium, sales were 4 per cent lower than in the same period last year, on 3 per cent higher volumes, which was due to a continuation of the more challenging environment outside of North America, as reported in previous announcements. Compared to the second quarter, contribution margins in the period were relatively stable in North America and improved for sales outside of the region, as a result of a better product mix.

Consistent with the strategy to reduce activity in Surfactants over time, sales in the period were 14 per cent lower than in the same period last year and operating profit was consistent with the previously reported near break-even run rate in the first six months of the year.

The Group’s tax rate for the full year is expected to be lower than it was for the first six months of the year, due to changes in the geographic mix of profits, but overall Group earnings per share for 2016 are expected to be in line with market expectations. The Group’s balance sheet remains strong, with robust operating cash generation continuing to be a positive feature of the Group’s performance. Consequently, the Group’s year end net cash balance is expected to be higher than the $74 million reported at the end of 2015.

END

Enquiries
Elementis plc Paul Waterman, CEO Brian Taylorson, CFO Ralph Hewins, CFO-DesignateTel: +44 (0) 20 7067 2999
FTI Consulting Deborah Scott Matthew ColeTel: +44 (0) 20 3727 1000
Date   Source Headline
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company
14th Jan 20207:00 amRNSTrading update
6th Jan 202010:09 amPRNHolding(s) in Company
2nd Jan 202011:12 amPRNTotal Voting Rights
2nd Dec 201912:15 pmPRNTotal Voting Rights
19th Nov 20197:00 amRNS2019 Capital Markets Day
1st Nov 20199:33 amPRNTotal Voting Rights
31st Oct 20197:00 amRNSQ3 Trading Update
4th Oct 20197:52 amPRNDirectorate Change
30th Sep 20197:00 amPRNAppointment of joint corporate broker
2nd Sep 201910:00 amPRNBlocklisting - Interim Review
15th Aug 201910:34 amPRNDirector/PDMR Shareholding
1st Aug 20193:42 pmPRNHolding(s) in Company
30th Jul 20197:00 amRNSHalf-year Report
25th Jul 201910:14 amPRNHolding(s) in Company
6th Jun 20195:42 pmPRNDirector/PDMR Shareholding
6th Jun 20195:39 pmPRNDirector/PDMR Shareholding
7th May 201910:33 amPRNDirector Declaration
7th May 20198:57 amPRNDirector Declaration
2nd May 20192:38 pmPRNHolding(s) in Company
30th Apr 20191:00 pmPRNResult of AGM
30th Apr 20197:00 amRNSAGM Trading Statement
18th Apr 20193:23 pmPRNHolding(s) in Company
17th Apr 20192:43 pmPRNHolding(s) in Company
3rd Apr 20199:31 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.